Skip to content
PubMed This is a summary of 43 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 43 referenced papers

Top Authors

Jean‐Laurent Casanova
Hôpital Necker-Enfants Malades
Jacinta C. Bustamante
Hôpital Necker-Enfants Malades
Seyed Alireza Mahdaviani
Masih Daneshvari Hospital
Davood Mansouri
Masih Daneshvari Hospital
Ali Akbar Velayati
Masih Daneshvari Hospital
Majid Marjani
Masih Daneshvari Hospital
Mahnaz Jamee
Shahid Beheshti University
Yunfei An
Children's Hospital of Chongqing Medical University
Xiaodong Zhao
Children's Hospital of Chongqing Medical University

Top Institutions

Ranked by publications Top 10 institutions
07

Alborz University of Medical Sciences

Karaj, Iran

5 papers
08

Children's Hospital of Chongqing Medical University

Chongqing, China

4 papers

References

References (43)
  1. 1

    Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin vaccination against tuberculosis in Iranian children.

    Mahmoudi S, Khaheshi S, Pourakbari B, et al.

    Clinical and experimental vaccine research 2015; (4(2)):195-9 doi:10.7774/cevr.2015.4.2.195.

    PMID: 26273579
  2. 2

    Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations.

    Lee PP

    Annals of the Academy of Medicine, Singapore 2015; (44(8)):297-301.

    PMID: 26477962
  3. 3

    Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders.

    Rosell AM, Pena LD, Schoch K, et al.

    Journal of genetic counseling 2016; (25(5)):1019-31 doi:10.1007/s10897-016-9933-1.

    PMID: 26868367
  4. 4

    Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.

    Zurynski Y, Deverell M, Dalkeith T, et al.

    Orphanet journal of rare diseases 2017; (12(1)):68 doi:10.1186/s13023-017-0622-4.

    PMID: 28399928
  5. 5

    Frequency of Mycobacterium bovis and mycobacteria in primary immunodeficiencies.

    Ulusoy E, Karaca NE, Aksu G, et al.

    Turk pediatri arsivi 2017; (52(3)):138-144 doi:10.5152/TurkPediatriArs.2017.5240.

    PMID: 29062247
  6. 6

    Disseminated Tuberculosis and Chronic Mucocutaneous Candidiasis in a Patient with a Gain-of-Function Mutation in Signal Transduction and Activator of Transcription 1.

    Pedraza-Sánchez S, Lezana-Fernández JL, Gonzalez Y, et al.

    Frontiers in immunology 2017; (8()):1651 doi:10.3389/fimmu.2017.01651.

    PMID: 29270166
  7. 7

    Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.

    Esteve-Solé A, Sologuren I, Martínez-Saavedra MT, et al.

    Critical reviews in clinical laboratory sciences 2018; (55(3)):184-204 doi:10.1080/10408363.2018.1444580.

    PMID: 29502462
  8. 8

    IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy.

    Ivashkiv LB

    Nature reviews. Immunology 2018; (18(9)):545-558 doi:10.1038/s41577-018-0029-z.

    PMID: 29921905
  9. 9

    Molecular, Immunological, and Clinical Features of 16 Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease.

    Sarrafzadeh SA, Nourizadeh M, Mahloojirad M, et al.

    Journal of clinical immunology 2019; (39(3)):287-297 doi:10.1007/s10875-019-0593-4.

    PMID: 30715640
  10. 10

    A Syrian Refugee in Iraq Diagnosed as a Case of IL12RB1 Deficiency in Japan Using Dried Blood Spots.

    Al-Kzayer LFY, Yassin AK, Salih KH, et al.

    Frontiers in immunology 2019; (10()):58 doi:10.3389/fimmu.2019.00058.

    PMID: 30740107
  11. 11

    Safety and tolerability of moxifloxacin for the treatment of disseminated BCGitis in children.

    Alsuhaibani M, Felimban G, Shoukri M, et al.

    International journal of pediatrics & adolescent medicine 2019; (6(2)):47-50 doi:10.1016/j.ijpam.2019.01.003.

    PMID: 31388545
  12. 12

    Loss of Janus Associated Kinase 1 Alters Urothelial Cell Function and Facilitates the Development of Bladder Cancer.

    Daza-Cajigal V, Albuquerque AS, Pearson J, et al.

    Frontiers in immunology 2019; (10()):2065 doi:10.3389/fimmu.2019.02065.

    PMID: 31552026
  13. 13

    Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review.

    Anand K, Burns EA, Ensor J, et al.

    Clinical lymphoma, myeloma & leukemia 2020; (20(1)):18-23 doi:10.1016/j.clml.2019.08.008.

    PMID: 31699655
  14. 14

    Inherited human IFN-γ deficiency underlies mycobacterial disease.

    Kerner G, Rosain J, Guérin A, et al.

    The Journal of clinical investigation 2020; (130(6)):3158-3171.

    PMID: 32163377
  15. 15

    Waiting for a diagnosis in Rubinstein-Taybi: The journey from "ignorance is bliss" to the value of "a label".

    Withers CM, Fleming J, Wallingford CK, et al.

    American journal of medical genetics. Part A 2021; (185(1)):105-111 doi:10.1002/ajmg.a.61920.

    PMID: 33063426
  16. 16

    Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.

    Zhang W, Chen X, Gao G, et al.

    Frontiers in immunology 2021; (12()):654406 doi:10.3389/fimmu.2021.654406.

    PMID: 33777053
  17. 17

    Disseminated Mycobacterium simiae Infection in a Patient with Complete IL-12p40 Deficiency.

    Mahdaviani SA, Marjani M, Jamee M, et al.

    Iranian journal of allergy, asthma, and immunology 2021; (20(3)):376-381 doi:10.18502/ijaai.v20i3.6339.

    PMID: 34134458
  18. 18

    Outcome of Hematopoietic Stem Cell Transplantation in patients with Mendelian Susceptibility to Mycobacterial Diseases.

    Radwan N, Nademi Z, Lum SH, et al.

    Journal of clinical immunology 2021; (41(8)):1774-1780 doi:10.1007/s10875-021-01116-1.

    PMID: 34387798
  19. 19

    Mendelian susceptibility to mycobacterial disease in tuberculosis-hyperendemic South Africa.

    Cornelissen HM, Glanzmann B, Van Coller A, et al.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2021; (111(10)):998-1005 doi:10.7196/SAMJ.2021.v111i10.15341.

    PMID: 34949297
  20. 20

    Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD): a case series.

    Mahdaviani SA, Fallahi M, Jamee M, et al.

    Annals of clinical microbiology and antimicrobials 2022; (21(1)):8 doi:10.1186/s12941-022-00500-y.

    PMID: 35232430
  21. 21

    Mendelian susceptibility to mycobacterial diseases: state of the art.

    Noma K, Mizoguchi Y, Tsumura M, Okada S

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2022; (28(11)):1429-1434 doi:10.1016/j.cmi.2022.03.004.

    PMID: 35283318
  22. 22

    Genetic and Functional Identifying of Novel STAT1 Loss-of-Function Mutations in Patients with Diverse Clinical Phenotypes.

    Chen X, Chen J, Chen R, et al.

    Journal of clinical immunology 2022; (42(8)):1778-1794 doi:10.1007/s10875-022-01339-w.

    PMID: 35976469
  23. 23

    Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria.

    Daza-Cajigal V, Albuquerque AS, Young DF, et al.

    Frontiers in immunology 2022; (13()):888427 doi:10.3389/fimmu.2022.888427.

    PMID: 36159783
  24. 24

    Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDS.

    Liu X, Zhu X, Zhou X, et al.

    Frontiers in immunology 2022; (13()):1012643 doi:10.3389/fimmu.2022.1012643.

    PMID: 36263041
  25. 25

    Novel STAT1 Variants in Japanese Patients with Isolated Mendelian Susceptibility to Mycobacterial Diseases.

    Ono R, Tsumura M, Shima S, et al.

    Journal of clinical immunology 2023; (43(2)):466-478 doi:10.1007/s10875-022-01396-1.

    PMID: 36336768
  26. 26

    Fibrosing mediastinitis in a child with Mendelian susceptibility to mycobacterial disease possibly due to Bacillus Calmette-Guérin.

    Sharifinejad N, Mahdaviani SA, Fallah S, et al.

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2022; (18(1)):96 doi:10.1186/s13223-022-00738-3.

    PMID: 36397171
  27. 27

    Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds.

    Errami A, Baghdadi JE, Ailal F, et al.

    Journal of clinical immunology 2023; (43(4)):728-740 doi:10.1007/s10875-022-01419-x.

    PMID: 36630059
  28. 28

    A rare mutation causing autosomal dominant STAT1 deficiency in a South African multiplex kindred with disseminated BCG infection.

    Greybe L, Leung D, Wieselthaler N, et al.

    BMC pediatrics 2023; (23(1)):378 doi:10.1186/s12887-023-04206-8.

    PMID: 37516851
  29. 29

    Mendelian susceptibility to mycobacterial diseases: State of the puzzle.

    Errami A, Bousfiha AA

    Qatar medical journal 2023; (2023(2)):25 doi:10.5339/qmj.2023.sqac.25.

    PMID: 38025345
  30. 30

    Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): A systematic review.

    Khavandegar A, Mahdaviani SA, Zaki-Dizaji M, et al.

    The Journal of allergy and clinical immunology 2024; (153(5)):1432-1444 doi:10.1016/j.jaci.2024.01.021.

    PMID: 38341181
  31. 31

    An atypical mycobacterial infection while on Janus kinase inhibitor therapy.

    Valek SA, Black TA, Aboul-Fettouh N, Rogge MN

    Dermatology online journal 2025; (31(2)) doi:10.5070/D331265289.

    PMID: 40991493
  32. 32

    Clinical recommendations for diagnosis and management of Mendelian susceptibility to mycobacterial disease in resource-limited settings.

    Cornelissen H, Glanzmann B, van Coller A, et al.

    The journal of allergy and clinical immunology. Global 2025; (4(4)):100540 doi:10.1016/j.jacig.2025.100540.

    PMID: 41048447
  33. 33

    Job's not done: BCG-itis as the first manifestation of hyper-IgE syndrome. A case report and review of the literature.

    Staines-Boone AT, Venegas-Montoya E, García Campos JA, et al.

    Clinical immunology (Orlando, Fla.) 2026; (282()):110639 doi:10.1016/j.clim.2025.110639.

    PMID: 41242409
  34. 34

    Case report: IL12RB1 deficiency in an infant with disseminated Bacille Calmette-Guérin disease.

    Ma X, Chen J, Cheng J, Wang J

    Frontiers in immunology 2025; (16()):1728612 doi:10.3389/fimmu.2025.1728612.

    PMID: 41668770
  35. 35

    What We Have Here Is a Failure to Communicate: Interleukin-12 / Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial Disease.

    Johnston AΜ, Rider NL, Freeman AF, et al.

    The journal of allergy and clinical immunology. In practice 2026; (14(7)):1529-1539 doi:10.1016/j.jaip.2026.02.026.

    PMID: 41786143
  36. 36

    Characteristics of Mycobacterial, COVID-19, and Talaromyces Marneffei Infections in Patients with IL12RB1 and IFNGR1 Mutations in Western China.

    Zhang W, Zhang Z, Liu C, et al.

    Journal of clinical immunology 2026; (46(1)).

    PMID: 41957131
  37. 37

    Pseudotumoral Pulmonary Mycobacterium avium Disease in a Patient on Ruxolitinib Therapy.

    Constantin AA, Iorga AL, Gaburici AD, Leonte I

    Diagnostics (Basel, Switzerland) 2026; (16(7)) doi:10.3390/diagnostics16071069.

    PMID: 41975780
  38. 38

    Mendelian susceptibility to mycobacterial disease: IFN-γ-driven immunity collapse underlies heterogeneous infections.

    Qian M, Zhou J, Zhou Q, et al.

    Frontiers in immunology 2026; (17()):1781297 doi:10.3389/fimmu.2026.1781297.

    PMID: 42183200
  39. 39

    Disseminated BCGosis in immunocompromised infants: a five-case series in the context of a national BCG vaccination policy change.

    Alhusaini W, Sanyour G, Kutbi R, et al.

    BMC pediatrics 2026; (26(1)).

    PMID: 42337472
  40. 40

    Lymph Node Cytology Raising Suspicion for Evolving Secondary Hemophagocytic Lymphohistiocytosis in a Case of Mendelian Susceptibility to Mycobacterial Disease.

    Soni D, Mukhopadhyay S, Panwar H, et al.

    Diagnostic cytopathology 2026; (54(11)):E292-E295 doi:10.1002/dc.70186.

    PMID: 42483808
  41. 41

    Tailored conditioning for hematopoietic stem cell transplantation in children with Mendelian susceptibility to mycobacterial disease: A tale of two pathways for IFN-γ and IL-12 defects.

    Ganesan K, Balwani M, Seshadri N, et al.

    Journal of human immunity 2026; (2(5)):e20250264 doi:10.70962/jhi.20250264.

    PMID: 42516312
  42. 42

    Persistent Ascites Revealing Mendelian Susceptibility to Mycobacterial Disease Due to IL-12Rβ1 Deficiency: A Case Report and Review of the Literature.

    Dolikhani M, Shakibamaram G, Rashtian P, et al.

    Case reports in immunology 2026; (2026()):3587297 doi:10.1155/crii/3587297.

    PMID: 42643649
  43. 43

    Pediatric Mycobacterium bovis Infection: Clinical Spectrum, BCG-Related Disease, Primary Immunodeficiency, and a Comprehensive Review of the Literature.

    Mete Atasever N, Dede E, Köksalan K, et al.

    Vaccines 2026; (14(10)) doi:10.3390/vaccines14100867.

    PMID: 42931396